Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 3 | -$1.15 | -$1.11 | -$1.13 |
| Q2 2026 | 5 | -$0.94 | -$0.85 | -$0.90 |
| Q3 2026 | 5 | -$0.76 | -$0.73 | -$0.75 |
| Q4 2026 | 5 | -$0.46 | -$0.39 | -$0.43 |
| Q1 2027 | 3 | -$0.65 | -$0.63 | -$0.64 |
| Q2 2027 | 3 | -$0.56 | -$0.53 | -$0.54 |
| Q3 2027 | 3 | -$0.43 | -$0.41 | -$0.42 |
| Q4 2027 | 3 | -$0.20 | -$0.19 | -$0.19 |
Biodesix Inc last posted its earnings results on Wednesday, August 5th, 2026. The company reported $-0.71 earnings per share for the quarter, topping analysts' consensus estimates of $-0.90179 by $0.19179. The company had revenue of 26.86 M for the quarter and had revenue of 88.50 M for the year. Biodesix Inc has generated $-5 earnings per share over the last year ($-4.67 diluted earnings per share) and currently has a price-to-earnings ratio of -8.4. Biodesix Inc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 08/05/2026 | Q2 2026 | -$0.90 | -$0.71 | 0.19 | $26.03 M | $26.86 M |
| 05/04/2026 | Q1 2026 | -$1.26 | -$0.81 | 0.45 | $23.12 M | $25.56 M |
| 02/26/2026 | Q4 2025 | -$1.05 | -$0.49 | 0.56 | $25.73 M | $28.76 M |
| 11/03/2025 | Q3 2025 | -$1.60 | -$1.16 | 0.44 | $20.97 M | $21.77 M |
| 08/07/2025 | Q2 2025 | -$1.40 | -$1.56 | -0.16 | $18.57 M | $20.02 M |
| 05/13/2025 | Q1 2025 | -$1.40 | -$1.51 | -0.11 | $19.42 M | $17.96 M |
| 03/03/2025 | Q4 2024 | -$0.07 | -$1.13 | -1.06 | $19.88 M | $20.43 M |
| 11/01/2024 | Q3 2024 | -$1.46 | -$1.40 | 0.06 | $18.57 M | $18.15 M |
| 08/07/2024 | Q2 2024 | N/A | -$1.70 | N/A | $16.13 M | $17.93 M |
| 05/08/2024 | Q1 2024 | -$2.84 | -$2.80 | 0.04 | $14.18 M | $14.82 M |
| 03/01/2024 | Q4 2023 | N/A | -$1.98 | N/A | $15.62 M | $14.67 M |
| 11/07/2023 | Q3 2023 | N/A | -$2.75 | N/A | $14.12 M | $13.49 M |
| 08/07/2023 | Q2 2023 | -$0.21 | -$3.40 | -3.19 | $11.67 M | $11.87 M |
| 05/11/2023 | Q1 2023 | -$0.24 | -$4.81 | -4.57 | $8.71 M | $9.06 M |
| 03/06/2023 | Q4 2022 | -$0.26 | -$7.04 | -6.78 | $10.77 M | $9.61 M |
| 11/03/2022 | Q3 2022 | -$6.40 | -$6.77 | -0.37 | $10.15 M | $11.11 M |
| 08/04/2022 | Q2 2022 | -$0.47 | -$8.07 | -7.61 | $8.83 M | $10.95 M |
| 05/11/2022 | Q1 2022 | -$7.60 | -$10.03 | -2.43 | $6.47 M | $6.55 M |
| 03/14/2022 | Q4 2021 | -$0.49 | -$9.82 | -9.33 | $7.29 M | $7.22 M |
| 11/15/2021 | Q3 2021 | -$10.00 | -$8.21 | 1.79 | $6.15 M | $6.53 M |
In the previous quarter, Biodesix Inc (:BDSX) reported $-0.71 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.90179 by $0.19179.
The conference call for Biodesix Inc's latest earnings report can be listened to online.
The conference call transcript for Biodesix Inc's latest earnings report can be read online.
Biodesix Inc (:BDSX) has a recorded annual revenue of $88.50 M.
Biodesix Inc (:BDSX) has a recorded net income of $-35,265,000.Biodesix Inc has generated $-4.67 earnings per share over the last four quarters.
Biodesix Inc (:BDSX) has a price-to-earnings ratio of -8.4 and price/earnings-to-growth ratio is -0.13.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED